Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |